Lynn A. Tetrault's Net Worth
$1.74 Million
Who is Lynn A. Tetrault?
Lynn A. Tetrault has an estimated net worth of $1.74 Million. This is based on reported shares across multiple companies, which include RHYTHM PHARMACEUTICALS, INC., NEOGENOMICS INC, and ACELYRIN, Inc..
SEC CIK
Lynn A. Tetrault's CIK is 0001645512
Past Insider Trading and Trends
2024 was Lynn A. Tetrault's most active year for acquiring shares with 9 total transactions. Lynn A. Tetrault's most active month to acquire stocks was the month of May. 2024 was Lynn A. Tetrault's most active year for disposing of shares, totalling 8 transactions. Lynn A. Tetrault's most active month to dispose stocks was the month of July. 2024 saw Lynn A. Tetrault paying a total of $123,157.00 for 111,242 shares, this is the most they've acquired in one year. In 2024 Lynn A. Tetrault cashed out on 49,048 shares for a total of $759,069.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
RHYTHM PHARMACEUTICALS, INC. (RYTM) Snapshot price: $49.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$30.77 | -$784,298.13 | 3K |
Scheduled
|
Sep 9 - Sep 10
| ||
Form 4
|
—
|
0
|
$34.50 | -$133,371.81 | 3K |
Scheduled
|
Aug 26
| ||
Form 4
|
—
|
0
|
$24.40 | -$404,961.81 | 3K |
Scheduled
|
Aug 12
| ||
Form 4
|
∞
| 3K |
—
|
—
| 3K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
NEOGENOMICS INC (NEO) Snapshot price: $16.04
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +22.64% | 11.34K |
—
|
—
| 61.4K |
Aug 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| -10.88% | -6.11K |
$15.97 | -$97,578.69 | 50.06K |
Scheduled
|
Mar 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 10
| |||
Form 4
| +2.76% | 1.51K |
$11.60 | $17,481.20 | 56.17K |
May 22
| |||
Form 4
| +39.77% | 15.56K |
—
|
—
| 54.67K |
Jun 10
| |||
Form 4
| +9.32% | 3.33K |
$7.27 | $24,238.18 | 39.11K |
May 18
| |||
Form 4
| +2.40% | 838 |
—
|
—
| 35.78K |
Oct 11
| |||
Form 4
| +4.14% | 1.39K |
$9.11 | $12,653.79 | 34.94K |
Jun 11
| |||
Form 4
| +10.11% | 3.08K |
—
|
—
| 33.55K |
Jun 2
| |||
Form 4
| +6.48% | 2.7K |
—
|
—
| 44.35K |
May 28
| |||
Form 4
| +8.94% | 3.42K |
—
|
—
| 41.65K |
Jun 6
| |||
Form 4
| -25.37% | -13.00K |
$16.00 | -$207,940.00 | 38.23K |
Nov 19
| |||
Form 4
| +37.19% | 13.89K |
$11.83 | $60,636.96 | 51.23K |
Nov 14 - Nov 15
| |||
Form 4
| +71.45% | 15.56K |
—
|
—
| 37.35K |
Jun 1
| |||
Form 4
| +49.60% | 7.22K |
—
|
—
| 21.78K |
May 25 - May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 4
| +14.77% | 2.15K |
$7.15 | $15,372.50 | 16.71K |
Apr 20
| |||
Form 4
| +187.75% | 9.5K |
$8.21 | $77,995.00 | 14.56K |
Dec 21
| |||
Form 4
| +224.36% | 3.5K |
$7.72 | $27,020.00 | 5.06K |
Dec 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACELYRIN, Inc. (SLRN) Snapshot price: $4.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |